EUVIMEDEUVIMED entdecken
Crossref

Timeliness of pre-operative aspirin before coronary artery bypass grafting (CABG): A clinical audit

Surendra Singh Yadav

Bioinformation · 31.10.2026 · 22 (10) · 7142-7145

DOI: 10.6026/973206300227142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Surendra Singh Yadav.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Omission or poorly timed aspirin before coronary artery bypass grafting (CABG) may compromise graft patency and post-operative outcomes. Therefore, it is of interest to evaluate the compliance with evidence-based recommendations for timely pre-operative aspirin administration at a tertiary care centre in Central India. A retrospective standards-based audit of 60 consecutive adult patients undergoing isolated CABG was conducted against predefined institutional standards. Aspirin was administered to 91.7% of eligible patients, and 86.7% received the last dose within 24 hours of surgery, exceeding the audit benchmark. Thus, medication omission, inadequate documentation and surgeon-directed discontinuation were the main causes of non-compliance, indicating a need for better documentation and medication reconciliation.

Zitieren

APA

Yadav, S. S. (2026). Timeliness of pre-operative aspirin before coronary artery bypass grafting (CABG): A clinical audit. Bioinformation, 22(10), 7142-7145. https://doi.org/10.6026/973206300227142

Vancouver

Yadav SS. Timeliness of pre-operative aspirin before coronary artery bypass grafting (CABG): A clinical audit. Bioinformation. 2026;22(10):7142-7145. doi:10.6026/973206300227142

BibTeX
@article{Yadav2026,
  author = {Yadav, Surendra Singh},
  title = {Timeliness of pre-operative aspirin before coronary artery bypass grafting (CABG): A clinical audit},
  journal = {Bioinformation},
  year = {2026},
  volume = {22},
  number = {10},
  pages = {7142--7145},
  doi = {10.6026/973206300227142}
}
Kostenlos starten →